69.30
-0.91 (-1.30%)
| Penutupan Terdahulu | 70.21 |
| Buka | 69.59 |
| Jumlah Dagangan | 288,178 |
| Purata Dagangan (3B) | 416,627 |
| Modal Pasaran | 3,332,222,208 |
| Harga / Pendapatan (P/E TTM) | 18.28 |
| Harga / Pendapatan (P/E Ke hadapan) | 14.51 |
| Harga / Jualan (P/S) | 3.09 |
| Harga / Buku (P/B) | 1.79 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 May 2026 |
| Margin Keuntungan | 18.86% |
| Margin Operasi (TTM) | 34.03% |
| EPS Cair (TTM) | 4.29 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 7.10% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 1.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 56.91% |
| Nisbah Semasa (MRQ) | 4.20 |
| Aliran Tunai Operasi (OCF TTM) | 251.52 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 188.69 M |
| Pulangan Atas Aset (ROA TTM) | 6.50% |
| Pulangan Atas Ekuiti (ROE TTM) | 12.30% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Prestige Consumer Healthcare In | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -3.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | -1.00 |
|
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.23% |
| % Dimiliki oleh Institusi | 108.15% |
| Julat 52 Minggu | ||
| Median | 66.00 (-4.76%) | |
| Jumlah | 1 Pegang | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Jefferies | 02 Feb 2026 | 66.00 (-4.76%) | Pegang | 65.44 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Feb 2026 | Pengumuman | Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results |
| 12 Jan 2026 | Pengumuman | Prestige Consumer Healthcare Announces Fiscal 2026 Third Quarter Earnings Results Date and Participation in the ICR Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |